Monitoring 14-3-3 protein interactions with a homogeneous fluorescence polarization assay

Journal of Biomolecular Screening

Volumn 11, Issue 3, 2006, Pages 269-276

  Du, Yuhong ^a   Masters, Shane C ^a,b   Khuri, Fadlo R ^a   Fu, Haian ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

14 3 3; Fluorescence polarization; Protein protein interaction

Indexed keywords

PHOSPHOPEPTIDE; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTEIN 14 3 3; PROTEIN INHIBITOR; R 18; RAF PROTEIN; RECOMBINANT PROTEIN; RHODAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE POLARIZATION; HIGH THROUGHPUT SCREENING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL NOISE RATIO; VALIDATION STUDY;

14-3-3 PROTEINS; FLUORESCENCE POLARIZATION IMMUNOASSAY; PROTEIN BINDING;

ESCHERICHIA COLI;

EID: 33646227205     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057105284862     Document Type: Article

References (35)

1. Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000;40:617-647.
2. Yaffe MB: How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 2002;513:53-57.
3. Muslin AJ, Xing H: 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 2000;12:703-709.
4. Dougherty MK, Morrison DK: Unlocking the code of 14-3-3. J Cell Sci 2004:117(Pt 10):1875-1884.
5. Aitken A, Baxter H, Dubois T, Clokie S, Mackie S, Mitchell K, et al: Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem Soc Trans 2002;30:351-360.
6. Muslin AJ, Tanner JW, Allen PM, Shaw AS: Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996;84:889-897.
7. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, et al: The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997;91:961-971.
8. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, et al: 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation, and trafficking. Biochem J 2004;379(Pt 2):395-408.
9. Meek SE, Lane WS, Piwnica-Worms H: Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem 2004;279:32046-32054.
10. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, et al: Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004;14:1436-1450.
11. Wilker E, Yaffe MB: 14-3-3 proteins: a focus on cancer and human disease. J Mol Cell Cardiol 2004;37:633-642.
12. Hermeking H: The 14-3-3 cancer connection. Nat Rev Cancer 2003;3:931-943.
13. Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH, et al: Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 2003;113:457-468.
14. Wang B, Yang H, Liu Y, Jelinek T, Zhang L, Ruoslahti E, et al: Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry 1999;38:12499-12504.
15. Masters SC, Fu H: 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem 2001;276:45193-45200.
16. Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H, et al: 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem 1998;273:16305-16310.
17. Pozuelo Rubio M, Peggie M, Wong BH, Morrice N, MacKintosh C: 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase. Embo J 2003;22:3514-3523.
18. Arkin MR, Wells JA: Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004;3:301-317.
19. Fotouhi N, Graves B: Small molecule inhibitors of p53/MDM2 interaction. Curr Top Med Chem 2005;5:159-165.
20. Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG: A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science 2004;305:1471-1474.
21. Zhang L, Wang H, Liu D, Liddington R, Fu H: Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49. J Biol Chem 1997;272:13717-13724.
22. Banks P, Gosselin M, Prystay L: Fluorescence polarization assays for high throughput screening of G protein-coupled receptors. J Biomol Screen 2000;5:159-168.
23. Lynch BA, Loiacono KA, Tiong CL, Adams SE, MacNeil IA: A fluorescence polarization based Src-SH2 binding assay. Anal Biochem 1997;247:77-82.
24. Owicki JC: Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen 2000;5:297-306.
25. Parker GJ, Law TL, Lenoch FJ, Bolger RE: Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J Biomol Screen 2000;5:77-88.
26. Wu P, Brasseur M, Schindler U: A high-throughput STAT binding assay using fluorescence polarization. Anal Biochem 1997;249:29-36.
27. Wu JJ, Yarwood DR, Pham Q, Sills MA: Identification of a high-affinity antiphosphoserine antibody for the development of a homogeneous fluorescence polarization assay of protein kinase C. J Biomol Screen 2000;5:23-30.
28. Jameson DM, Mocz G: Fluorescence polarization/anisotropy approaches to study protein-ligand interactions: effects of errors and uncertainties. Methods Mol Biol 2005;305:301-322.
29. Zhang L, Chen J, Fu H: Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA 1999;96:8511-8515.
30. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al: Current Protocols in Molecular Biology. New York: John Wiley, 1987.
31. Fu H, Coburn J, Collier RJ: The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc Natl Acad Sci USA 1993;90:2320-2324.
32. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
33. Truong AB, Masters SC, Yang H, Fu H: Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins 2002;49:321-325.
34. van Hemert MJ, van Heusden GP, Steensma HY: Yeast 14-3-3 proteins. Yeast 2001;18:889-895.
35. Ferl RJ: 14-3-3 proteins: regulation of signal-induced events. Physiol Plant 2004;120:173-178.